- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01471873
Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked Corneas
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Pentacam Classic (Oculus Optikgerate GmbH, Heidelberg, Germany, software version 1.14r04) was used for the sake of the study.Two study groups were formed: 1) Keratoconus group (KC) included patients with progressive keratoconus and 2) Collagen-Cross-linking group (CXL) included keratoconus patients that had been treated with uneventful CXL at least on year prior to their enrollment in the study.
Three consecutive scans were obtained by two experienced operators. The same procedure was repeated within two weeks for the assessment of intersession variability. In all cases acceptable maps had at least 10.0mm of corneal coverage.All back elevation points were codified in order to facilitate statistical processing of data. Further to single point analysis, three additional parameters were evaluated: a) zone 4 parameter (z4) which derived by the analysis of all points at the central 4.0mm diameter zone, b) zone 8 parameter (z8) which derived by the analysis of all points at the central 8.0mm diameter zone, and, c) highest elevation point parameter (HEP), which derived by the analysis of the highest elevation points for all participants. Reproducibility of measurements was evaluated by means of intraclass correlation coefficients (ICC). Three different ICC types were calculated: a) intrasession ICC for both operators (ICC1 & ICC2), b) interobserver ICC, and, c) intersession ICC. Moreover, Bland-Altman plots were used to evaluate the level of agreement between the two operators.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Thrace
-
Alexandroupolis, Thrace, Greece, 67100
- Eye Institute of Thrace (EIT)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Progressive keratoconus (Keratoconus group)
- Corneal collagen cross linking (CxL) treatment at least one year prior to enrollment (CxL group)
Exclusion Criteria:
- Glaucoma
- Suspicion of glaucoma
- history of herpetic keratitis
- corneal scarring
- severe eye dryness
- pregnancy or nursing
- current corneal infection
- underlying autoimmune disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Collagen-Cross-linking group (CXLG)
Collagen-Cross-linking group (CXLG) included keratoconus patients that had been treated with uneventful corneal collagen cross-linking (CXL) at least on year prior to their enrolment in the study.
|
The same surgical procedure was applied to all CXLG patients that included: Instillation of proparacaine hydrochloride 0.5% drops for topical anaesthesia, application of a sponge saturated with 10% alcohol to the central cornea for 20-30 seconds and subsequent de-epithelialization by means of a hockey knife. Following de-epithelialization, a mixture of 0.1% riboflavin in 20% Dextran solution was instilled to the cornea for 30 minutes (2 drops every 2 minutes) prior to the irradiation. In details, an 8.0mm diameter of central cornea was irradiated for 30 minutes by UVA light with a wavelength of 370nm and an irradiance of 3mW/cm2.The UVA radiation source that was used is the UV-XTM (IROC AG, Zurich, Switzerland). Instillation of riboflavin drops (1 drop every 2 minutes) was continued during irradiation, as well. |
|
Keratoconus Group (KG)
Keratoconus group (KG) included patients with progressive keratoconus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variability of posterior corneal surface elevation measurements within and between sessions and within and between observers.
Time Frame: 2 weeks
|
The Pentacam Classic (Oculus Optikgerate GmbH, Heidelberg, Germany, software version 1.14r04) was used for the sake of the study.
Three consecutive scans were obtained by two experienced operators for the assessment of intrasession and interobserver variability.
The same procedure was repeated within two weeks for the assessment of intersession variability.Bland-Altman plots were used to evaluate agreement between the 2 operators.
The reproducibility of all measurements was evaluated by means of the intraclass correlation coefficient(ICC).
|
2 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25/27-09-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Glaukos CorporationRecruitingProgressive KeratoconusUnited States
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruitingKeratoconus, StableChina
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Ain Shams UniversityCompletedKeratoconus | Keratoconus PosteriorEgypt
-
Kasr El Aini HospitalCompletedProgressive KeratoconusEgypt
-
Comprehensive EyeCare of Central OhioGlaukos CorporationCompleted
Clinical Trials on Corneal Collagen Cross-linking (CXL)
-
Benha UniversityCompletedCollagen Diseases | Keratoconus | Corneal DiseaseEgypt
-
Bruce AllanMoorfields Eye Hospital NHS Foundation TrustCompleted
-
Oslo University HospitalRecruiting
-
Yonsei UniversityCompletedModerate KeratoconusKorea, Republic of
-
Democritus University of ThraceCompleted
-
Cairo UniversityCompleted
-
Shahid Beheshti University of Medical SciencesUnknownKeratoconusIran, Islamic Republic of
-
Minia UniversityRecruiting
-
Woolfson Eye InstituteRecruitingKeratoconus | Pellucid Marginal Degeneration | Forme Fruste Keratoconus (FFK) | Down Syndrome (DS)United States